Risk assessment, screening and prevention of breast cancer: A look at cost-effectiveness.

American Society of Breast Disease, Frisco, TX 75034, United States.
Breast (Edinburgh, Scotland) (Impact Factor: 2.58). 08/2010; 19(4):260-7. DOI: 10.1016/j.breast.2010.03.013
Source: PubMed

ABSTRACT Recent suggestions by the United States Preventive Task Force to change the longstanding guidelines for screening mammography have raised the issue of cost-effectiveness in regards to breast cancer detection. Given the enormous number of women who have had, or who will be diagnosed with breast cancer, it is essential to maintain the quality of care that has been achieved here in the United States while utilizing a cost-effective approach. The following review attempts a close examination of current methods available for risk assessment, screening and prevention programs. These programs must be carefully considered and analyzed prior to implementing cost-saving changes to current clinical standards that have proven successful in decreasing the mortality from breast cancer throughout the world.

Download full-text


Available from: Alan B Hollingsworth, Mar 13, 2015
  • Source
    Mammography - Recent Advances, 03/2012; , ISBN: 978-953-51-0285-4
  • [Show abstract] [Hide abstract]
    ABSTRACT: Brain activity during interaction with seal robot "Paro" was measured by functional near-infrared spectroscopy (fNIRS). In the pilot study, there were two experimental tasks: Interaction with Paro that was switched ON (Paro ON) and Paro that was switched OFF (Paro OFF) with one minute rest before and after the tasks. The results showed significant activations around the pre-motor area and the supplementary motor area (SMA) during Paro OFF task compared with rest condition before the task. These areas are supposed to be a function of initiating action. This indicates that when participants touched and interacted with Paro, they might intentionally interact. On the other hand, there were significant increased brain activations on both sides of the Sylvian fissure during Paro ON task compared with rest condition before the task. The results suggest that when participants interacted with Paro, they might recognize the emotional gesture expression of Paro. They might communicate with Paro naturally without intention of interaction.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Biomarkers are the measurable characteristics of an individual that may represent risk factors for a disease or outcome, or that may be indicators of disease progression or of treatment-associated changes. In general, the process by which biomarkers, once identified, might be translated into clinical practice has received scant attention in recent psychiatric literature. A body of work in diagnostic development suggests a framework for evaluating and validating novel biomarkers, but this work may be unfamiliar to clinical and translational researchers in psychiatry. Therefore, this review focuses on the steps that might follow the identification of putative biomarkers. It first addresses standard approaches to characterizing biomarker performance, followed by demonstrations of how a putative biomarker might be shown to have clinical relevance. Finally, it addresses ways in which a biomarker-based test might be validated for clinical application in terms of efficacy and cost-effectiveness.
    Molecular Psychiatry 06/2011; 16(11):1076-87. DOI:10.1038/mp.2011.63 · 15.15 Impact Factor